INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136547, 839, 0.01, 0.01, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d03330cc4dd7cf4ed74fc92f4e55f0f455d028a92cc84c4eccc9a95430d03332d535c985c869020022400d65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136548, 839, 1.0, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d43553c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010079780901', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136549, 839, 0.5, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d535cb4dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010080a90943', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136550, 839, 0.5, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010084720960', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136551, 839, 0.75, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d03337d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c01008b0c0997', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136552, 839, 0.01, 0.01, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d03330cc4dd7cf4ed74fc92f4e55f0f455d028a92cc84c4eccc9a95430d03332d535c985c869020022400d65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136553, 839, 1.0, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d43553c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010079780901', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136554, 839, 0.5, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d535cb4dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010080a90943', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136555, 839, 0.5, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010084720960', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136556, 839, 0.75, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d03337d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c01008b0c0997', X'789ced5a7b6fda4810ff2aab48d5b53a488024b447ab9328b44ad4a645497ad2e9a8acc53bd82bec5ddfee3a8d53e5bbdfaccd6b0d2986bea41eff005ecfcccee3378fb5f97cc0541a7882c670d02107975c27a03893020e6ae42055915d0d8d4974e7e8e8139f407c2855607ff1a312b1f6154d8079d4589e56a3d5ae379af566e3baf1acd368768e4f0f9f9db49b7f3ccb69c1375c0a8d949f0fba2ce6826ba3a85dcb970cdce652aeb3043aa46bb284fb341a0a2a0c4f74e687d2707f28fa52d300c86ba962dd218dc3d6691cd4f03bff6ada8f96fd38b61f2771f0dcae1dc56f87e252a606349163e26ede21ef158d6ae4fc62287a328ea520d78a3220efd041b8456132a3516e443a5ab6e31e970c1d4560affef98857111793fc62619063c06617771df2fb8f768f2e4b23e3a1e95c048eb3d6e87470e587fc4e26a102c1a943fda27d4a32896ed28640c2b5643014cdfa314117319a91c17bc2f80d67c0c8bfec68c4d9505cd0db0e69b60b82a198498829170630367e2ee1e40b12daa7bf23cb262ab40d83f3e79c445105514662a980c0786cedbbc921b7e46eeb99973c9111551e436b140355f32c7ebc66cdebfa186f2fa602bdb8ec8466bdbdc9de19c19afdae65aac0a0e0ab4c3025f3145ac8b6707cc09df599f807a57f014cf9d6bf765ccb28fe1f05f6bb9b5af6ed4fb4f51b6f5dbd1ee7bb0f80716a14f7abd6d20543a2a40f2cc556e16960ab6dab71d8b09d6682aa21e4b19b90c7d3168670cfed3a898b7b4fd6a0cfc96daf5539d83b56445a52fdb4dede628773a5382ef1889b0ca5a6067b297a68b6a147b5963eba0dd8ca360f97a40752b2008b5e0f96a7db08ac8e8d6f1cea2ff6e77dac7f46acbf2604bb34aa7d0c76eb7a5bfaad1c9a5fd371dfcdaa7563c28f33ebeb77db7218b84a00dd14790399a4115d983ddb71a020b09370462ef1ae08867854ec0dc55bea9b9c9a28ae2776f15c8cf18c975f129f0a210d1901516984dae1a1138f9e3851479da1c88f71f8dd53bd88bc386e74c895a1cad8d32b1a465e9ef7890941102e7c05145bcb282b4eb6f9ad4f00930867f5b37e87bcc33d188cb9001c8ae69d0b452fdda8110d40a8dd93b07cdc3944664850797f59999047ac3e488390f422c40ee9ad518b0ab641abea4aec7a8e2ec763f351ba6f9f7314c4dae3c29b4b38c00d1782dd886e163ba7f72cbde763aa05527154be38adf7a4300a0f520c4782555875a30854901123896ffd7d649fc66018689a3f8d58f2e41165125de203822b311aefcc3d70ac18419218b4013514af224c7c1c3e72aa3ec4c8c1691d4f5ab60a90e26982e67a8a44c2e3847265a9e68070d606544db8d052fca6499f6b1b740c2aa40ad5492c714c236e35316496ab43116219920a917005fc0e877c325fe851c5b8bca1dac73c5398b853897d4e47609fc9c41061314b51bfab94fb98d5f340ec82932f2bba39bc4bfcde9c7f51941ce8ac9850019453166fce327bc673034a837709d45f45cdda41121497a94b779625120ff01a8986a23614a8b62f1374f6ab5bc46492291a738610d0599c18196bc49bb1e1b901c2328d5107cde9e660a3e410bbb5c272a562cb7066af8228f321bfc4fb6c35bab8da7fd39d23245f18284e13aee3fce2ca283929d6afcf91b09fe924a48195f816d2091a22a6d25141a45d5c770345451a493f3305d20b2451db242da0f3da6538f6ca35fdbb78ece766e9841a0430a735eb172385fd95ccf202f5ad61fe412c95b5a638231c0db10f181ea430b5ffeecebad3da4d46916d6e8cdc701b999a7daa79cbc1aa5623be14e3b408d825d5e1d4977808892c108475680dcb2c0f4243022c2bb5792566842609a055601f5d0a1c03925c9399ff950aa1708fa0a9b63f51c71b19f3a29d7d505c5095597158b170a7fca94f4f622bb07a7db83c47cf85121d6a0165b0df160aa311294208f3d8a46a649f156dd1ebd7427573d62c133b193805f86609575342877b15fb9b055d173cde128f23f347d69fe524ace4c405b523c749df8a82e6e48ea495b4dfa9223a35f64db7820c2472b8a635a6022ea6840ef7ac2a6d669f53babbe785acc2e6059dc38b95af0208cf4bf62eea63850166415b46eeaca85682e99cd891522ac515de789418dc48944af786682c533b72a6a579b388d753c212aaa7c5bc0a9a67a48e8469c1aff2fea72074b86d63a8f076ce52397ccb5d6133bf435dceeabc99544ae682d2e12ffa4f055015740eefac616de6fe6b4659f20136b42ac65bb26216db4f56bb4e56e519753f5aed47abfd68b51fadf6a3d57eb4da8f56fbd16a3f107c8b816097c7a2fb2cdd6769e52c1d8454c5d497910c32f71444a3713de263e8905623248f07ef9f3c27c7f536b16fe51e9f5f3c198a0b402cca08f3b643a66f176aa4f7f7a0d56fdbc312a653f1b74b9b12409e361ed5c86bf071ac699e3cdae135de05f821b555c29363afebaffc5be3839808f909f3f4f4ecbadec2040cf9881ba96c9ed30928d25f5adce5352280d78db4744bdaf29f38b12a39d7c4c85b3c42992dffc1f490f42dff525a4acb8735db42a637e743f8dcdfff0777102d07', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136557, 914, 800.0, 1200.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb5b23030d035343230c84dd74f49ac5408f057c8cc5348c92ccb4c494d01ab280600bb21111f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136558, 914, 4.0, 12.0, 'mg', NULL, NULL, 'Adult', X'789c0bc9482d4a2c482d2dc94c56284acc4b4fb55230d13534ca4dd7f751d03034d3b3d43535d0b350c8cd4c2ecacfcdcf492dd6f7d10400be031025', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136559, 914, 1600.0, 1600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4eb55230343330c84dd74f49ac54d0284a2c4acda95430d433d335d233010b6a020016a70c9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136560, 914, 400.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb552303130d0b53030c84dd74f49ac5408f057c8cc5348c92ccb4c494d01ab280600b9081110', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136561, 914, 1200.0, 1200.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4eb55230343230c84dd74f49ac0400424f0650', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136562, 914, 200.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cccb2cc94ccc51303230c84d5708f05728543034ca50c8cc4b2e4a4d2c4e5548aa8448e9a72456020036c50de4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136563, 914, 1600.0, 1600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4e5530343330c84dd74f49ac04003cc9061a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136564, 914, 100.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c333430d0353330c84d5708f05728f40856282d5028c9573055284f4dcd2e060078c908b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136565, 914, 200.0, 1300.0, 'mg', NULL, NULL, 'Adult', X'789c333230d035343630c84dd74f49ac5448cb2f5230d233d5b550284f4dcd2e060079260885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136566, 914, 100.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789c333430d0353230c84d5708f057287449acd451c84dac54c8cc4b2e4a4d2c4e5528cec92fcfa95428c95730042bd34f49ac04009c461081', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136567, 914, 10.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cccb2cc94cccb15228494cca492dd1553034d03532c84dd7cf4ed74f5108f05728b4d03534cad051282e2d2e48cd2bcecccfd3c55062960100231f15dc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136568, 914, 35.0, 35.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c0dc9c10d80201004c056b601c303fdd883455cb8955c94232a1ae95ebf338b9837ba78e28c221d6a8f29b19e3c6e7aeaf8bf220e239a155e50b1bdc36bc3cf7c13a98853c961cb41a57f93e71c5b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136569, 914, 50.0, 50.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cccb2c49ccb152282e2d2e48cd2bcecccfd3553035c84d5708f0572834cbd05128494cca492dd155303480891a1a018573132b1532f3928b52138b53150a15ca5353b315922a21aaf453122b01012d1c63', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136570, 914, 400.0, 800.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb552303130d0b53030c84dd74f49ac5408f0572834d3b5c850d0c8cccd4d4dc94c2c4955284acd494d2c4ed5d45128343402cab806690200bd99145c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136571, 914, 200.0, 200.0, 'mg', 'PO', NULL, 'Pediatric', X'789c1d8dbb0a023110457fe5961b3090dd42c4ad2d0441b1b11e6534c13c7633b3857f6f48773887cb3de7a081e211b2c9c25942c916a34b170c9373e96370bb62ddfb194acfc86ad175b7e3e47748f443c8afca248cf5c1fced01c3e96ee6b6b487c6453d57bc4b4d5b246d1f62fe12de2670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136572, 25269, 1.0, 1.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c55cc310ec2300c05d0abfc850d44ab8a850189910bb0073089451c07db2deaed59e100ef9defef998d1e108a42a2b9ea8d1b09a7234648debf322e57e84286c36e1a84db16925618754a016e180b3e1c057347e82fe2e7ff8a4a0b557870ad384dc3066af0557aa8383a99b3c7172f30321c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136573, 25269, 1.0, 2.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73292a4dd7cdcc4b294d4e4d51c84d2dc948cdcd4fcfc94fcacc4bcdcd4cb45230d43552c84dd7cf4e57f00c5328cec92fcfa954c82f4b2d52284e059289390ab99979a525a9c500b7cd1a3d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136574, 1780, 1.5, 2.0, 'mg', NULL, NULL, 'Adult', X'789c33d433d53552c84d57f073755228543053c82802002bdb04be', X'789ced596d6fdb3610fe2b0703fbb4f8454ed26eee30202f5d5b2069b2242d30d481404b67890b456a2495582bf2df77a4e417ba69ed662f18b67c6a25dd1d9fbb7b9e3b45fed8497595c59215d81941e7b04ad128c953ecec40a7d2c2ddccad2dcda8dfbfe33758f494cedcff783fb435896625a631b3ce6538183eeb0ea26e34b81a3c1fed7d3f1a46bd287a4eb7bd2d26962b69c8f263e7202db8e4c66ae6eef95b16673eca555de2682cdfc89c094c2151daf244198b5af1742c8f956119c24f4a176604bb707c319617aab268404d218c3b8236ca581ea9a25012ae344b11de52e2e47c5e8982bbf81e5e355945784fb72c9b0874571faee94a7079e32f96501fc6b8b988ad5fbce6777fed4e3d482b61634a93cb2c284cd4dbef0ea1c8e0edcb43f80d9e41ae5d39402a0b059fc11db739289ba30689934af0df095a81294f7c310c309982e6d2201454b01cd8940e86cae0d7e5ef519e535c66354f1e427a606c5eb0b12c1897162593098e65d4fd0e6ad5a02c35571a265ac924572917ccd225134a92dda037dcef0e7afb94693f65b5cf36e5b7c4b8147e3eee1ebe391ecb4bcbb41dc1d26a2c4fd96cf5460faeb86301825520d41d1a0b389dba0c6f115265b0f71024de767441378f26da0e4b0025fa73409466e2112822782c08b8222587e742466aa99810754b951f23b843bc21c02f5dd3559973c113a08150e62ce3969bb1fc218a2895e668383f238030dbeb4643ef49cf4f89a91ed6b038f199f8a4f7210353d1341184c5819c92be9dbb1195d6359d7870eb104d954afb2991f80666bb03a2bd6ca1214b729f081533fad623187e01817bd6df5b45100dfe32088f1d278d6c368f8fd6ae19179725269c89f85c959560cb093b0f7aae31730aace1829eca6c4c53f1f005b805e00626e98f27e87225e2794b0b2519a2b4a6e5236a4313956e006b757dc212eb8fa271626e5cc493dd1770c9a6686ba8e48d547792a632295fb882d0a9233fa5529c72e9a6f16b7467240f3ddca1e124b99b07896b84a81f5bcdf5c437d7f5d82dc5c6d8c45cc68b081d3a701938cc7e73d8857decec639ac69829cd097cd3c12325499b5c2e0675384b85409dd58e908960c6f45de7888b6d2b768025b4fce886fba7ed10e08c25a8273edc581e3673d694cc144b7b4f6636d155697da353cdee98f8a7b8bb5ad0cf42df229c738d1bd738709d2fd35ba22fc61724ce4f6bfb40b29d4ba4f95badf540b232af059bb901b75a4d6272edf481d2d0f4bb25f6ebf6a01d5a2589e8816626a762cb8c2b4cd175ec20d55e18a62a4971c6f8161d552627da81a965aa55816de0e60581bb835e6975476a0cbc56a630053eca2b9d752f894b95312b915e095625ca1d7dc4684b103ecae28c14ad4aa52982e9840d6e38e95e9782227c7857ba054187975cbb855d538ad3a674d7d724774aa0590147aaca28e933eb2efd1b089dfd9ebbcdb2f0706088f1f4c838971dbf78082bb5522b9a35d4051febbd2a7833b68e39d33a4757c1494a775d0d4b920d95a1a4f9d43487b4f46b25dd5a6bdc2fa8fcebe96dc7e765cbb760e18a71c8ec45dfb709b2b00d62ac536373a4d6235e7804f15649b33956601de27a906e5ba05bf5fb0cc6396537475b5886d81c03b780e2cd02cf55d26e0ed058c78d758860c9ee2d70ac18877508e5b04539d61c8268732d6d0eb3b00cfce70adc6293ce2d433504badd421173fbd8db872c9e6b7e0b0a2f4cd738b23a2ab6214b601fc49a8f992f47f056ed5bdbff73cbac2fdba735f3b4669ed6ccd39a795a337fcf9af9afcdd7c7fc65fa24d22791feab457a9e335db0440995d581545f3331ed0a3ec5110c7bbbfe73ff2912df95a077b5119cf05bd42fe0e897f3bdfdc108760ff6c0e9c37fe72535cd128dcd8f20ef349708cf06dfec00c9161f7a13dbf4b9ff14939c493a3656d3f820f9e4479b3732e7136e492c95b0bc14e846846045d14c98a4b6ea864034bf41945aa515e1581a6782b66bfb6b88fb2a4546d46ca459b2bcd97caf363d7839a3974b52658b68fec1b1f7b569dddfff014b6163e9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136575, 1780, 0.25, 0.5, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d535d03355c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401009c7f0986', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136576, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab15230d03355c84dd74f49ac04003075055d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136577, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230d03355c84dd74f49acd45308c92c294a2c495528c957c8c92f4f2d2e51484d4b4b4d2ec92c4b5548c92f4ed503009dfd112b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136578, 1780, 0.25, 1.0, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d53554c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401008fb50924', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136579, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab15230d033cd4dd74f49ac04002c99053d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136580, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523054c84dd74f49acd45308c92c294a2c495528c957c8c92f4f2d2e51484d4b4b4d2ec92c4b5548c92f4ed5030089f710c9', X'789ced596d6fdb3610fe2b0703fbb4f8454ed26eee30202f5d5b2069b2242d30d481404b67890b456a2495582bf2df77a4e417ba69ed662f18b67c6a25dd1d9fbb7b9e3b45fed8497595c59215d81941e7b04ad128c953ecec40a7d2c2ddccad2dcda8dfbfe33758f494cedcff783fb435896625a631b3ce6538183eeb0ea26e34b81a3c1fed7d3f1a46bd287a4eb7bd2d26962b69c8f263e7202db8e4c66ae6eef95b16673eca555de2682cdfc89c094c2151daf244198b5af1742c8f956119c24f4a176604bb707c319617aab268404d218c3b8236ca581ea9a25012ae344b11de52e2e47c5e8982bbf81e5e355945784fb72c9b0874571faee94a7079e32f96501fc6b8b988ad5fbce6777fed4e3d482b61634a93cb2c284cd4dbef0ea1c8e0edcb43f80d9e41ae5d39402a0b059fc11db739289ba30689934af0df095a81294f7c310c309982e6d2201454b01cd8940e86cae0d7e5ef519e535c66354f1e427a606c5eb0b12c1897162593098e65d4fd0e6ad5a02c35571a265ac924572917ccd225134a92dda037dcef0e7afb94693f65b5cf36e5b7c4b8147e3eee1ebe391ecb4bcbb41dc1d26a2c4fd96cf5460faeb86301825520d41d1a0b389dba0c6f115265b0f71024de767441378f26da0e4b0025fa73409466e2112822782c08b8222587e742466aa99810754b951f23b843bc21c02f5dd3559973c113a08150e62ce3969bb1fc218a2895e668383f238030dbeb4643ef49cf4f89a91ed6b038f199f8a4f7210353d1341184c5819c92be9dbb1195d6359d7870eb104d954afb2991f80666bb03a2bd6ca1214b729f081533fad623187e01817bd6df5b45100dfe32088f1d278d6c368f8fd6ae19179725269c89f85c959560cb093b0f7aae31730aace1829eca6c4c53f1f005b805e00626e98f27e87225e2794b0b2519a2b4a6e5236a4313956e006b757dc212eb8fa271626e5cc493dd1770c9a6686ba8e48d547792a632295fb882d0a9233fa5529c72e9a6f16b7467240f3ddca1e124b99b07896b84a81f5bcdf5c437d7f5d82dc5c6d8c45cc68b081d3a701938cc7e73d8857decec639ac69829cd097cd3c12325499b5c2e0675384b85409dd58e908960c6f45de7888b6d2b768025b4fce886fba7ed10e08c25a8273edc581e3673d694cc144b7b4f6636d155697da353cdee98f8a7b8bb5ad0cf42df229c738d1bd738709d2fd35ba22fc61724ce4f6bfb40b29d4ba4f95badf540b232af059bb901b75a4d6272edf481d2d0f4bb25f6ebf6a01d5a2589e8816626a762cb8c2b4cd175ec20d55e18a62a4971c6f8161d552627da81a965aa55816de0e60581bb835e6975476a0cbc56a630053eca2b9d752f894b95312b915e095625ca1d7dc4684b103ecae28c14ad4aa52982e9840d6e38e95e9782227c7857ba054187975cbb855d538ad3a674d7d724774aa0590147aaca28e933eb2efd1b089dfd9ebbcdb2f0706088f1f4c838971dbf78082bb5522b9a35d4051febbd2a7833b68e39d33a4757c1494a775d0d4b920d95a1a4f9d43487b4f46b25dd5a6bdc2fa8fcebe96dc7e765cbb760e18a71c8ec45dfb709b2b00d62ac536373a4d6235e7804f15649b33956601de27a906e5ba05bf5fb0cc6396537475b5886d81c03b780e2cd02cf55d26e0ed058c78d758860c9ee2d70ac18877508e5b04539d61c8268732d6d0eb3b00cfce70adc6293ce2d433504badd421173fbd8db872c9e6b7e0b0a2f4cd738b23a2ab6214b601fc49a8f992f47f056ed5bdbff73cbac2fdba735f3b4669ed6ccd39a795a337fcf9af9afcdd7c7fc65fa24d22791feab457a9e335db0440995d581545f3331ed0a3ec5110c7bbbfe73ff2912df95a077b5119cf05bd42fe0e897f3bdfdc108760ff6c0e9c37fe72535cd128dcd8f20ef349708cf06dfec00c9161f7a13dbf4b9ff14939c493a3656d3f820f9e4479b3732e7136e492c95b0bc14e846846045d14c98a4b6ea864034bf41945aa515e1581a6782b66bfb6b88fb2a4546d46ca459b2bcd97caf363d7839a3974b52658b68fec1b1f7b569dddfff014b6163e9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136581, 1780, 0.25, 1.0, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d53554c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401008fb50924', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136582, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab1523054c84dd74f49ac0400280504fb', X'789ced596d6fdb3610fe2b0703fbb4f8454ed26eee30202f5d5b2069b2242d30d481404b67890b456a2495582bf2df77a4e417ba69ed662f18b67c6a25dd1d9fbb7b9e3b45fed8497595c59215d81941e7b04ad128c953ecec40a7d2c2ddccad2dcda8dfbfe33758f494cedcff783fb435896625a631b3ce6538183eeb0ea26e34b81a3c1fed7d3f1a46bd287a4eb7bd2d26962b69c8f263e7202db8e4c66ae6eef95b16673eca555de2682cdfc89c094c2151daf244198b5af1742c8f956119c24f4a176604bb707c319617aab268404d218c3b8236ca581ea9a25012ae344b11de52e2e47c5e8982bbf81e5e355945784fb72c9b0874571faee94a7079e32f96501fc6b8b988ad5fbce6777fed4e3d482b61634a93cb2c284cd4dbef0ea1c8e0edcb43f80d9e41ae5d39402a0b059fc11db739289ba30689934af0df095a81294f7c310c309982e6d2201454b01cd8940e86cae0d7e5ef519e535c66354f1e427a606c5eb0b12c1897162593098e65d4fd0e6ad5a02c35571a265ac924572917ccd225134a92dda037dcef0e7afb94693f65b5cf36e5b7c4b8147e3eee1ebe391ecb4bcbb41dc1d26a2c4fd96cf5460faeb86301825520d41d1a0b389dba0c6f115265b0f71024de767441378f26da0e4b0025fa73409466e2112822782c08b8222587e742466aa99810754b951f23b843bc21c02f5dd3559973c113a08150e62ce3969bb1fc218a2895e668383f238030dbeb4643ef49cf4f89a91ed6b038f199f8a4f7210353d1341184c5819c92be9dbb1195d6359d7870eb104d954afb2991f80666bb03a2bd6ca1214b729f081533fad623187e01817bd6df5b45100dfe32088f1d278d6c368f8fd6ae19179725269c89f85c959560cb093b0f7aae31730aace1829eca6c4c53f1f005b805e00626e98f27e87225e2794b0b2519a2b4a6e5236a4313956e006b757dc212eb8fa271626e5cc493dd1770c9a6686ba8e48d547792a632295fb882d0a9233fa5529c72e9a6f16b7467240f3ddca1e124b99b07896b84a81f5bcdf5c437d7f5d82dc5c6d8c45cc68b081d3a701938cc7e73d8857decec639ac69829cd097cd3c12325499b5c2e0675384b85409dd58e908960c6f45de7888b6d2b768025b4fce886fba7ed10e08c25a8273edc581e3673d694cc144b7b4f6636d155697da353cdee98f8a7b8bb5ad0cf42df229c738d1bd738709d2fd35ba22fc61724ce4f6bfb40b29d4ba4f95badf540b232af059bb901b75a4d6272edf481d2d0f4bb25f6ebf6a01d5a2589e8816626a762cb8c2b4cd175ec20d55e18a62a4971c6f8161d552627da81a965aa55816de0e60581bb835e6975476a0cbc56a630053eca2b9d752f894b95312b915e095625ca1d7dc4684b103ecae28c14ad4aa52982e9840d6e38e95e9782227c7857ba054187975cbb855d538ad3a674d7d724774aa0590147aaca28e933eb2efd1b089dfd9ebbcdb2f0706088f1f4c838971dbf78082bb5522b9a35d4051febbd2a7833b68e39d33a4757c1494a775d0d4b920d95a1a4f9d43487b4f46b25dd5a6bdc2fa8fcebe96dc7e765cbb760e18a71c8ec45dfb709b2b00d62ac536373a4d6235e7804f15649b33956601de27a906e5ba05bf5fb0cc6396537475b5886d81c03b780e2cd02cf55d26e0ed058c78d758860c9ee2d70ac18877508e5b04539d61c8268732d6d0eb3b00cfce70adc6293ce2d433504badd421173fbd8db872c9e6b7e0b0a2f4cd738b23a2ab6214b601fc49a8f992f47f056ed5bdbff73cbac2fdba735f3b4669ed6ccd39a795a337fcf9af9afcdd7c7fc65fa24d22791feab457a9e335db0440995d581545f3331ed0a3ec5110c7bbbfe73ff2912df95a077b5119cf05bd42fe0e897f3bdfdc108760ff6c0e9c37fe72535cd128dcd8f20ef349708cf06dfec00c9161f7a13dbf4b9ff14939c493a3656d3f820f9e4479b3732e7136e492c95b0bc14e846846045d14c98a4b6ea864034bf41945aa515e1581a6782b66bfb6b88fb2a4546d46ca459b2bcd97caf363d7839a3974b52658b68fec1b1f7b569dddfff014b6163e9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136583, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789c0dcab10d80300c04c0557e82a0b4146c40c70216f9a0882023c710d81edad3cdf28c8838b621c91bb0143771c215553b9b833973f57213491bff21270d6a52d19ca62561334997d4fa42f24f98223ab9870fd287206d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136584, 1780, 1.0, 1.0, 'mg', 'PO', 1, 'Pediatric', X'789cb3313454a8ccb7523054c84d5708f057087451a830d1353452284f4dcd2e0600766b0835', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136585, 1780, 1.0, 1.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cdac503054c84dd737caf551f073755228cf2cc95030554857282e4d2e4accc92f4e5528c95748cb2fca5508f05728ce292d2aaad40300cf2811c1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136586, 1780, 2.0, 2.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d456a8ccb7523052c84d5708f057087451a830d1353452284f4dcd2e0600748f0825', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136587, 1780, 2.0, 2.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cdac503052c84dd737c9f551f073755228cf2cc9503034504857282e4d2e4accc92f4e5528c95748cb2fca5508f05728ce292d2aaad40300dbe711f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136588, 2064, 300.0, 300.0, 'mg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b055303630c84d57f00c5348cacf292d5648cbcfc9c92f4f4d5148aa543034054941c40382fc0021bb12c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136589, 2064, 150.0, 150.0, 'mg', 'IN', NULL, 'Adult', X'789c33343550c84d57c8cc53303430c8f55170310d57c82f4b2d02727381821a86a640697d20535347212d3f2727bf3c354521a952c1102aac9052945900d161965154aca0616c0636b024bf24314713001b1d1ca6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136590, 2064, 0.5, 0.5, 'mg', NULL, NULL, 'Adult', X'789c0bc948cd5330d03355c84dd7cfcdcc534829ca2c50c82f4b2d52c84bad285130b450c8282a56d030353100aa5028c92f49ccd10400b596106c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136591, 2064, 400.0, 800.0, 'mg', 'IV', 1, 'Adult', X'789cf32f4acc5148c92f4e4c4f55484c2b492d52f00c53c8cc4b2b2dcecccf53c82c5630313050d0b50012b9e90a01fe0a298999399500e3061119', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136592, 149, 50.0, 100.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3335d0353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834cb0000858c094d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136593, 149, 4.0, 4.0, 'g', 'IV', NULL, 'Adult', X'789c335148d74f49ac54f00c5348c92ccb4c494d512834cb00004d050710', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136594, 149, 75.0, 100.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cc29b1523037d5353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d51284ccf0000b80f0b00', X'789ced5a6d4f1bc716fe2b474895886a8c2121b9d7f79371698202b92e902a5775648d678f77a7ccceec9d17876dc57fef99591b6358b3b0a46aa4f69b373be799f37e9eb3e4f7adc4f874a2588e5b7dd81a66521b9617192ac1b5dceac0963732bcc99c2b6c7f77f78bb8c4bcab4d1a7e89dd1a01cb0d2b30993017e4f67bfbaf777a7b3b7bbd8bde9bfe41afbfffb2fbefdec1cb7f1dc4b3c89dd0cad2c9dfb7dea242c364fcedf02a8a5f9405f661cab84323b475cc093e564c3931153afefe415b9622fca84d6efb70fc73078e4f3b802542627461c76aa8f35c2bb8302c41f84086d2b102956379c9d109d5011e8cd08bc7a8969fded6ec9afec9b1a9c4f0f4cb677a92425dc68795a62b9d9abd36589dbdfe1cd00789976e42a60895aed95fa3cdd6b19a558f9d499dcb0e7ae4ec5e9eee5ea6bb092bc9259088b9483081ffbfceb6d66d09971f56de6572925314552a9cb06b88afa00e69ac06d2f5e1cdc1e6ebd287afe35afdea159932bf7765af7bf01de822731993b9e060b5f4c164d88b61859f8e7f809936f006e84e7bf7960702165578b607ef86e4efe7c23fdbe2cd1efe064cfeaa2a3cbed9442d469808e68ce08f6d1775919aecaf893d148ed7d97fe0945dc1abf8ea6ba4c9b32e7fa2b7ce0be4e1f6912ebc642ba72c2f1f194c699cf0b20f43e630d5a684216c1b612f416907c64bd2437bf762ac4ec8960841f383598b1684721aa6069975900b79094c256033ed6502530436d7d10c3183425b2b48cdb13a43c52454b1eb9394123993b204bce2061d9d9e0b0697225158d2f08a83a10f2cd75eb9a8518233a13019ab9b44a87ffd0e8b302c573721f9494bf11b5d312dc1650852ccd174c24f8394933431b545c83d5943da1b4c3c0f486d756811aea156ce30a112c16b823590124d4aba6be09222b01bb84b8b5b0609d96d7172868cdfbfa5ae86ce03fbf0ebe758413a040f3385b960c44a52c394979a978e7c4ec17319b18a697c26c2118f285664a56457e1351d2f89da50306ca9a839e4941d85459fd0af7c4a58742310a98a3de6fe10a878cd9a4a19b284f18c7014f3165907e63a2771958ec9a5cc183a30a6d947e68f956196dab13764023341b9828c242247d310147a6a56cc65e5584da53726e6a5257f3ca1016c74d52308d24260b210a05b566877ddda0c777157620def56501e43dd56872beef64de4c6dd84fd2739be8de4f8ebe2f0545a91319333ca289d966beabe6372b623c58cd6b0bdee01ecc0abee1ed0883394a5a78b9962f33e9c88a8f0511c6371487e343405c2219e31456740cf60c0ab7753eaf13634f283de391831d556d3180452da2be168b066b420059f4061b443a1421dd0a0b2b5e9ded8f06ff6adc9392a2b2ae286cd7dff3dae3be37cacacb71c0b1786f9ae5d80216c7bebc318279a703c26a243a4278fb3915ecd43e4a634e26f8b9a608aa3a59124ce28cecb47d82672188628cee28e42d89c8ca1f057e8e7df930a25ed2ca98845f345b80c384a095fe804acb6500acf473a7aa361209d1f2f8e412bd2645be9e051eb307054b15c8708ffd31ee5a52672ea28d93eed535baa94a00890cf8ceec0d457539e7237b9a51b9d7ef9c0e9d5c15b96059dde1aed0b188075060b28280dcb8a2602bdbcd1cc42e231e4cb5117660c092874c94fafdadcb8b889ca874ab3ea109b9b1635aaa86188fe5bc37218e9caa141ecbf268d991d5323a07697e674e0b003c30ebcdd8a13629973653c5975981bd80d48a3a582d802e3676144c2c86dd1d81a804f7b8fd382513094a6cc85b415cc512805cd35e704b18c5c0dd0f1537184cf5bc09c9e9f0fda889dd58a9d35880d073b1b241fe17e1a255d382a688330b9486a9dd6787f177e451a51f5be6a923ee902e55f1c8c292aac53e06e1ac60af980290b1562ef027ee8424a8034e134b6ca6a02b85923eb3dd28470aa0dbba26ec980168c306b37a46313cebb6ee84dd2a3faad9525d4c6027b6b21f95ee2d48a6082ad2bc8c63aaa2ede5dc1c0d1f9e1c9f76da0ee21bd1f0deb809a12adaaedea23af2d3a30c88b21b19bf46b41d1f2dd028a78bda13cae777373fd2ea421678623cd7dd54a0726a9043706bb719264226d2d3c0ac48b9a6d2e0c9b8afa326974c31264ee654a34a84de72788f035487172a62dba6db4a0aaa78798a22d1186815b54690533839e987a5df13e0927098c9926eb73715a9a34a042a1e462c4115a65f88013bd770f2bd194dfa36aa58d5a30343e720dd602e8d09bcb4ccb247c6b243a5c302eea609aa9171275a4ad2a5b28454b09ad8519a57f1bb8ff517c898432c0057b09fb3a6f83f423adfc5cd898c2ce4b6682789bc175683c7fa0109ac44f3015fa599534a2dd9d16d708917bf22e27a2da06e81dc33c86c687e580b6ceb2b622f71b99f2d4081d1a941233c1ebcbf12ec8a9b0fc5e496692e565125562f535d5c84e4aaec3c78d7cb59db4211767825fa273563c438dc59f5c7d0e6c5e4f1fef0568a05898bdf7795f58fa55fcfbeaa39c7b2f65a32ae1533a317fc3d24db3a8096764704ed328261e4afa6715786dbb7a1c4a4d9b15915072502266943842d685aa69b8ddc6d98edfce97602fda74096f6f054e218f9dccd486af71fc63e174dc1edd72eddad8323edfffe4f2cf9793bfc79793a7fe3d0e71329056afe5c6eaf39c85ed5326d48ba72137213df63f63d8c942e6faf3f5f5f51fdcf8ae5d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136595, 149, 75.0, 100.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3337d5353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834cbb056f04dac5030014b01000be50cfd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136596, 24893, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523035c84dd72fcb4ccc010088d909a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);